ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,640Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 663

$462K Total Retail Price of All Prescriptions

Rank: 84 out of 663

981 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 981 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 981 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 1,046 978 1 1
LISINOPRIL 577 556 2 2
OMEPRAZOLE 517 465 3 4
ATENOLOL 454 430 4 10
AMLODIPINE BESYLATE 410 386 5 5
HYDROCODONE-ACETAMINOPHEN 339 272 S3 6 6
LEVOTHROID 300 273 7 19
METOPROLOL TARTRATE 287 279 8 11
FUROSEMIDE 278 255 9 7
METFORMIN HCL 258 234 10 9
GLIPIZIDE 248 218 11 29
ALENDRONATE SODIUM 246 224 12 15
LEVOTHYROXINE SODIUM 245 212 13 3
WARFARIN SODIUM 216 205 14 8
OXYCODONE-ACETAMINOPHEN 211 194 S2 15 26
K-TAB 200 188 16 36
TERAZOSIN HCL 176 149 17 38
FLUTICASONE PROPIONATE 175 157 18 27
TAMSULOSIN HCL 165 165 19 24
ZOLPIDEM TARTRATE 160 136 20 16
TRIAMTERENE-HYDROCHLOROTHIAZID 157 145 21 49
ALLOPURINOL 148 139 22 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 130 23 22
ATORVASTATIN CALCIUM 139 121 24 13
PROAIR HFA 138 124 25 33
LOSARTAN POTASSIUM 134 116 26 14
RANITIDINE HCL 129 115 27 31
PRAVASTATIN SODIUM 127 120 28 21
OXYCODONE HCL 116 83 S2 29 41
NOVOLIN N 109 105 30 44
TRAMADOL HCL 109 101 30 17
FLUOXETINE HCL 106 93 32 32
CITALOPRAM HBR 105 103 33 18
METOPROLOL SUCCINATE 103 94 34 25
TRIAMTERENE-HCTZ 102 102 35 42
HYDROCHLOROTHIAZIDE 100 95 36 12
INSULIN SYRINGE 92 89 37 55
FENOFIBRATE 84 69 38 97
PREDNISONE 83 80 39 39
MORPHINE SULFATE ER 81 60 S2 40 51
TRAZODONE HCL 80 69 41 34
OXYBUTYNIN CHLORIDE 80 56 41 99
DIGOXIN 72 71 43 50
GABAPENTIN 66 65 44 20
CIPROFLOXACIN HCL 54 48 45 74
ROPINIROLE HCL 53 44 46 140
DILT-XR 52 50 47 100
MIRTAZAPINE 52 52 47 52
NORTRIPTYLINE HCL 51 51 49 63
CLOPIDOGREL 51 49 49 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.